BlackRock Group LTD - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Group LTD ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$2,130,000
+77.4%
84,363
+73.8%
0.00%0.0%
Q3 2016$1,201,000
+74.8%
48,540
+44.0%
0.00%
Q2 2016$687,000
+43.4%
33,698
+7.4%
0.00%
Q1 2016$479,000
+2.1%
31,382
-9.9%
0.00%
Q4 2015$469,000
+23.7%
34,842
+29.0%
0.00%
Q3 2015$379,000
-34.3%
27,008
-20.6%
0.00%
Q2 2015$577,00033,9960.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders